Sitagliptin triazecine analog
CAS: 2088771-61-1
Ref. 3D-FS180825
| 1g | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
Sitagliptin is a pharmaceutical drug that belongs to the group of dipeptidyl peptidase-4 (DPP-4) inhibitors. It is used to lower blood glucose levels in people with type 2 diabetes by increasing insulin release from the pancreas and by reducing the rate of breakdown of glucose-lowering medication. Sitagliptin can be administered orally, as an extended-release tablet or as an injection. It binds to human monocytes and reduces their production of proinflammatory cytokines such as TNF-α and IL-6, which are involved in the pathogenesis of atherosclerosis, diabetes, and obesity. Sitagliptin also has antihyperglycemic effects in animals.
Chemical properties
Technical inquiry about: 3D-FS180825 Sitagliptin triazecine analog
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
